STAGE II URETER CANCER AJCC V7
Clinical trials for STAGE II URETER CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE II URETER CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE II URETER CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immune drug aims to stop bladder cancer return after surgery
Disease control OngoingThis phase 3 trial tests whether the immune-boosting drug pembrolizumab can help prevent bladder cancer from coming back after surgery. About 739 patients with muscle-invasive or locally advanced urothelial cancer will receive either pembrolizumab or just observation. The study m…
Matched conditions: STAGE II URETER CANCER AJCC V7
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 23, 2026 11:56 UTC
-
Immunotherapy combo shows promise for bladder cancer patients unable to get chemo
Disease control OngoingThis early-phase trial is testing whether giving two immunotherapy drugs (durvalumab and tremelimumab) before surgery can help patients with aggressive bladder cancer who cannot take standard chemotherapy. The study involves 54 participants and primarily looks at safety and how t…
Matched conditions: STAGE II URETER CANCER AJCC V7
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 23, 2026 11:55 UTC